These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 22242331

  • 1. [Progress in the management of multiple myeloma introduced by serum free light chain measurement].
    Fuchida S, Shimazaki C.
    Nihon Rinsho; 2011 Dec; 69(12):2267-73. PubMed ID: 22242331
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K, Itoh J, Sugiura I, Tsushita K, Kosugi H, Nagura E.
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [Abstract] [Full Text] [Related]

  • 3. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG, International Myeloma Working Group.
    Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
    [Abstract] [Full Text] [Related]

  • 4. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP, Cobbold M, Wang Y, Goodall M, Bonney SL, Chamba A, Birtwistle J, Plant T, Afzal Z, Jefferis R, Drayson MT.
    J Immunol Methods; 2013 May 31; 391(1-2):1-13. PubMed ID: 23388695
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F, Thiry C, Willems D.
    Clin Biochem; 2007 Mar 31; 40(5-6):351-4. PubMed ID: 17239359
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI.
    Ann Hematol; 2005 Sep 31; 84(9):588-93. PubMed ID: 15883850
    [Abstract] [Full Text] [Related]

  • 8. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
    Levinson SS.
    Ann Clin Lab Sci; 2010 Sep 31; 40(4):348-53. PubMed ID: 20947809
    [Abstract] [Full Text] [Related]

  • 9. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.
    Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR.
    Blood; 2001 May 01; 97(9):2900-2. PubMed ID: 11313287
    [Abstract] [Full Text] [Related]

  • 10. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
    Campbell JP, Heaney JL, Shemar M, Baldwin D, Griffin AE, Oldridge E, Goodall M, Afzal Z, Plant T, Cobbold M, Jefferis R, Jacobs JF, Hand C, Drayson MT.
    Clin Chem Lab Med; 2017 Mar 01; 55(3):424-434. PubMed ID: 27505089
    [Abstract] [Full Text] [Related]

  • 11. Serum free light chains: diagnostic and prognostic value in multiple myeloma.
    Sthaneshwar P, Nadarajan V, Maniam JA, Nordin N, Gin Gin G.
    Clin Chem Lab Med; 2009 Mar 01; 47(9):1101-7. PubMed ID: 19728852
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadogiannis A, Galanis Z, Kalpadakis C, Dimou M, Kyriakou E, Angelopoulou MK, Dimopoulou MN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Panayiotidis P, Pangalis GA.
    Br J Haematol; 2007 May 01; 137(3):240-3. PubMed ID: 17408464
    [Abstract] [Full Text] [Related]

  • 13. [Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma].
    Maruyama Y, Hayashi T, Ikeda H, Yasui H, Ishida T, Shinomura Y.
    Rinsho Ketsueki; 2013 Jan 01; 54(1):122-6. PubMed ID: 23391656
    [Abstract] [Full Text] [Related]

  • 14. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
    Sui WW, Yao HJ, Wang YF, Wang L, Zhang K, Xu Y, Qiu LG.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3158-60. PubMed ID: 18269880
    [Abstract] [Full Text] [Related]

  • 15. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
    Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M.
    Amyloid; 2005 Dec 27; 12(4):210-5. PubMed ID: 16399645
    [Abstract] [Full Text] [Related]

  • 16. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use.
    Hansen CT, Münster AM, Nielsen L, Pedersen P, Abildgaard N.
    Eur J Haematol; 2012 Dec 27; 89(6):458-68. PubMed ID: 22998393
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D, Lemaire-Ewing S, Denimal D, Bastie JN, Lafon I, Caillot D.
    Ann Biol Clin (Paris); 2013 Dec 27; 71(2):157-63. PubMed ID: 23587579
    [Abstract] [Full Text] [Related]

  • 18. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
    Boyle EM, Fouquet G, Guidez S, Bonnet S, Demarquette H, Dulery R, Herbaux C, Noel MP, Manier S, Schraen S, Onraed B, Faucompré JL, Hennache B, Petillon MO, Mathiot C, Avet-Loiseau H, Facon T, Harding SJ, Moreau P, Leleu X.
    Cancer; 2014 Dec 15; 120(24):3952-7. PubMed ID: 25116271
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA.
    Clin Chem; 2005 May 15; 51(5):878-81. PubMed ID: 15774572
    [Abstract] [Full Text] [Related]

  • 20. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders.
    Vermeersch P, Vercammen M, Holvoet A, Vande Broek I, Delforge M, Bossuyt X.
    Clin Chim Acta; 2009 Dec 15; 410(1-2):54-8. PubMed ID: 19778527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.